Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3102 ARTÍCULOS , VIENDO DEL 691 AL 705

Metoclopramide-induced encephalopathy in Parkinson disease

Robottom BJ, Shulman LM, Anderson KE, Weiner WJ.

South Med J. 2010 Feb;103(2):178-80. doi: 10.1097/SMJ.0b013e3181ca9b3f.

1-Benzyl-1,2,3,4-tetrahydroisoquinoline binds with tubulin beta, a substrate of parkin, and reduces its polyubiquitination

Kohta R, Kotake Y, Hosoya T, Hiramatsu T, Otsubo Y, Koyama H, Hirokane Y, Yokoyama Y, Ikeshoji H, Oofusa K, Suzuki M, Ohta S.

J Neurochem. 2010 Sep 1;114(5):1291-301. doi: 10.1111/j.1471-4159.2010.06576.x. Epub 2010 Jan 8.

Complications and side effects of deep brain stimulation in the posterior subthalamic area

Fytagoridis A, Blomstedt P.

Stereotact Funct Neurosurg. 2010;88(2):88-93. doi: 10.1159/000271824. Epub 2010 Jan 5.

Secondary failure after ten years of pallidal neurostimulation in a patient with advanced Parkinson's disease

Allert N, Lehrke R, Sturm V, Volkmann J.

J Neural Transm (Vienna). 2010 Mar;117(3):349-51. doi: 10.1007/s00702-009-0363-1.

Orbital involvement in Castleman disease

Venizelos I, Papathomas TG, Papathanasiou M, Cheva A, Garypidou V, Coupland S.

Surv Ophthalmol. 2010 May-Jun;55(3):247-55. doi: 10.1016/j.survophthal.2009.09.003. Epub 2010 Jan 13.

Parkin-mediated ubiquitin signalling in aggresome formation and autophagy

Chin LS, Olzmann JA, Li L.

Biochem Soc Trans. 2010 Feb;38(Pt 1):144-9. doi: 10.1042/BST0380144.

Systematic evaluation of rating scales for drug-induced parkinsonism and recommendations for future research

Knol W, Keijsers CJ, Jansen PA, van Marum RJ.

J Clin Psychopharmacol. 2010 Feb;30(1):57-63. doi: 10.1097/JCP.0b013e3181c914b3.

Parkinsonism in patients with chronic hepatitis C treated with interferon-alpha2b: a report of two cases

Kajihara M, Montagnese S, Khanna P, Amodio P, Schapira AH, Dusheiko GM, Morgan MY.

Eur J Gastroenterol Hepatol. 2010 May;22(5):628-31. doi: 10.1097/MEG.0b013e32833383e3.

Genitourinary dysfunction in Parkinson's disease

Sakakibara R, Uchiyama T, Yamanishi T, Kishi M.

Mov Disord. 2010 Jan 15;25(1):2-12. doi: 10.1002/mds.22519.

Reckless generosity in Parkinson's disease

O'Sullivan SS, Evans AH, Quinn NP, Lawrence AD, Lees AJ.

Mov Disord. 2010 Jan 30;25(2):221-3. doi: 10.1002/mds.22687.

Differentiating vascular parkinsonism from idiopathic Parkinson's disease: a systematic review

Kalra S, Grosset DG, Benamer HT.

Mov Disord. 2010 Jan 30;25(2):149-56. doi: 10.1002/mds.22937.

Self-management rehabilitation and health-related quality of life in Parkinson's disease: a randomized controlled trial

Tickle-Degnen L, Ellis T, Saint-Hilaire MH, Thomas CA, Wagenaar RC.

Mov Disord. 2010 Jan 30;25(2):194-204. doi: 10.1002/mds.22940.

Pathological roles of MAPK signaling pathways in human diseases

Kim EK, Choi EJ.

Biochim Biophys Acta. 2010 Apr;1802(4):396-405. doi: 10.1016/j.bbadis.2009.12.009. Epub 2010 Jan 14.

Extending palliative care to patients with Parkinson's disease

Wilcox SK.

Br J Hosp Med (Lond). 2010 Jan;71(1):26-30. doi: 10.12968/hmed.2010.71.1.45969.

Neurodegenerative dementia and parkinsonism

Gabelle A, Portet F, Berr C, Touchon J.

J Nutr Health Aging. 2010 Jan;14(1):37-44. doi: 10.1007/s12603-010-0007-z.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias